NCT03766347Completed
Pediatric NMOSD Observational Study
Pediatric Neuromyelitis Optica Spectrum Disorder (NMOSD) 1 Year Observational Study
Source: ClinicalTrials.gov · Last updated 10 Apr 2024
Brief summary (registry, in English)
This study is being done to develop a database of pediatric patients in order to study the cause, early detection and best treatment for neuromyelitis optica spectrum disorder (NMOSD) in pediatric patients.
- Status (registry)
- Completed
- Study type
- Observational
- Enrollment
- 100 (actual)
- First submitted
- 4 Dec 2018
- Start date
- 1 Feb 2018
- Primary completion date
- 3 Apr 2024
- Lead sponsor
- Mayo Clinic
- Diseases
- Neuromyelitis optica (NMOSD)
- NCT number
- NCT03766347
What you commit to
- Study type: Observational
- Participants enrolled: 100
- From 1 Feb 2018 to the primary completion date, 3 Apr 2024
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other
- \- Inability to complete required forms via phone, mail, or email.
Who the study is looking for
- AQP4 positive
- Ability to give informed consent by patient or caregiver
Age in the registry: 2 years to 17 years · Sex: All · Does not accept healthy volunteers
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Mayo Clinic Coordinator of this site? Confirm its status | Rochester | United States | Unknown status |
This page is information, not medical advice. Discuss any trial with your doctor.